Systemic lupus erythematosus with presentation as vertigo and vertical nystagmus: Report of one case

Acta Paediatrica Taiwanica

Volumn 44, Issue 3, 2003, Pages 158-160

  Liao, Chiang Hua ^a,b   Yang, Yao Hsu ^a   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

Kikuchi disease; Nystagmus; Systemic lupus erythematosus; Vertigo

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN; MANNITOL; RIBOSOME P ANTIBODY; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CORNEA REFLEX; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; ELECTRONYSTAGMOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FACIAL EXPRESSION; FEVER; GAIT DISORDER; HEADACHE; HUMAN; KIKUCHI DISEASE; LABORATORY TEST; LEUKOPENIA; MALE; MEDULLA OBLONGATA; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PHYSICAL EXAMINATION; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; VERTIGO; VIRUS ENCEPHALITIS;

CHILD; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NYSTAGMUS, PATHOLOGIC; VERTIGO;

EID: 0041821855     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994; 20:129-58.
2. Sibley JT, Wojceich P, Olszynski WSP, et al. The incidence and prognosis of central neurous system disease in SLE. J Rheumatol 1992; 19:47-52.
3. Futrell N, Schultz LR, Millikan C. Central nervous systemic disease in patients with SLE. Neurology 1992; 42:1649-57.
4. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971; 50:85-95.
5. Feng PH, Cheah PS, Lee YK. Mortality in systemic lupus erythematosus: a 10-year review. Br Med J 1973; 4:772-4.
6. Rosener S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus: 1. causes of death. Arthritis Rheum 1982; 25:612-7.
7. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus: a clinical pathological study of 24 cases and review of the literature. Medicine 1968; 47:337-69.
8. Devinsky O, Pettito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli and thrombotic thrombocytopenic purpura. Ann Neurol 1988; 23:380-4.
9. DD Cruz. Vasculitis in systemic lupus erythematosus. Lupus 1998; 7:270-4.
10. Kerr GS, Hoffman GS. Systemic lupus erythematosus and the cardiovascular system: vasculitis. In: Systemic lupus erythematosus. 2nd ed. Lahita RA, ed. New York: Churchill, Livingstone, 1992; 719-29.
11. Susan J. Herdman. Vestibular rehabilitation, Philadelphia: F. A. Davis, 2000; 264-87.
12. Jouhikainen T, Julkunen H, Vaarala O, et al. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients. Blood Coagul Fibrinolysis 1992; 3:407-14.
13. Triplett DA. Protean clinical presentation of antiphospholipid-protein antibodies. Thromb Haemostasis 1995; 74:329-37.
14. Horbach DA, Van Oort E, Derksen RH, de Groot PG. The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity discrimination between functional and non-functional anti-prothrombin-antibodies. Thromb Haemostasis 1998; 79:790-5.
15. Ferro D, Saliola M, Quintarelli G, et al. Methods of detecting lupus anticoagulatants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus. J Clin Path 1992; 45:332-8.
16. Hulsey M, Goldstein R, Scully L, Surbeck W, Reichlin M. Anti-ribosomal P antibodies in systemic lupus erythematosus: a case-control study correlating hepatic and renal disease. Clin Immunol Immunopathol 1995; 74:252-6.
17. Rivero SJ, Diaz-Jouanen E, Alarcon-Segovia D. Lymphopenia in systemic lupus erythematosus: clinical, diagnostic, and prognostic significance. Arthritis Rheum 1978; 21:295-305.
18. Alarcon-Segovia D et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992; 21:275-86.
19. Cervera R et al. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis 1990; 9:109-13.
20. Karassa FB, Ioannidis JPA, Touloumi G, Boki KA, Moutsopoulos HM. Risk factors for central nervous system involvement in systemic lupus erythematosus. Q J Med 2000; 93:169-74.
21. Gonzalez-Crespo MR et al. Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatol 1995; 34:1055-60.
22. Miller DH et al. Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus. J Neurol 1992; 239:460-4.
23. Chen YH, Lan JL. Kikuchi disease in systemic lupus erythematosus: clinical features and literature review. J Microbiol Immunol Infect 1998; 31:187-92.